ArticleInternational journal of hematology2026

Azacitidine monotherapy versus combination regimens as post-HSCT maintenance therapy in high-risk myeloid malignancies: a retrospective cohort study.

Ying Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.